JP2024508171A5 - - Google Patents
Info
- Publication number
- JP2024508171A5 JP2024508171A5 JP2023553692A JP2023553692A JP2024508171A5 JP 2024508171 A5 JP2024508171 A5 JP 2024508171A5 JP 2023553692 A JP2023553692 A JP 2023553692A JP 2023553692 A JP2023553692 A JP 2023553692A JP 2024508171 A5 JP2024508171 A5 JP 2024508171A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- oxadiazine
- trifluoromethyl
- phenyl
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156193P | 2021-03-03 | 2021-03-03 | |
| US63/156,193 | 2021-03-03 | ||
| PCT/EP2022/055211 WO2022184748A1 (en) | 2021-03-03 | 2022-03-02 | Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508171A JP2024508171A (ja) | 2024-02-22 |
| JP2024508171A5 true JP2024508171A5 (enExample) | 2025-03-11 |
Family
ID=80780814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553692A Pending JP2024508171A (ja) | 2021-03-03 | 2022-03-02 | 肉腫の処置のための置換３，６－ジヒドロ－２ｈ－１，３，４－オキサジアジン－２－オン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230405015A1 (enExample) |
| EP (1) | EP4301371A1 (enExample) |
| JP (1) | JP2024508171A (enExample) |
| CN (1) | CN117279644A (enExample) |
| CA (1) | CA3212314A1 (enExample) |
| TW (1) | TW202302113A (enExample) |
| WO (1) | WO2022184748A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120187704A (zh) * | 2022-11-24 | 2025-06-20 | 盛睿泽华医药科技（苏州）有限公司 | 吡啶酮化合物及其制备方法和用途 |
| CN118420559B (zh) * | 2023-04-27 | 2025-02-14 | 上海超阳药业有限公司 | 氘代噁二嗪酮化合物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6150361A (en) * | 1998-12-22 | 2000-11-21 | Bayer Corporation | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| JP6445573B2 (ja) * | 2013-10-17 | 2018-12-26 | サルタル セラピューティクス エルティーディＳａｒｔａｒ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ | ヒト患者の固形腫瘍の治療に用いるためのホスホジエステラーゼ阻害剤含有組成物 |
| CN106573931A (zh) * | 2014-06-18 | 2017-04-19 | 拜耳医药股份有限公司 | 抑制BET蛋白的具有间位取代的芳族氨基或醚基的3，4‑二氢吡啶并[2，3‑b]吡嗪酮 |
| WO2017027854A1 (en) * | 2015-08-13 | 2017-02-16 | The Broad Institute, Inc. | Compositions and methods for cancer expressing pde3a or slfn12 |
| TW201733591A (zh) * | 2016-02-05 | 2017-10-01 | 拜耳製藥公司 | 用於癌症病人分級及癌症治療之化合物、組合物及方法 |
| US11142522B2 (en) * | 2017-02-03 | 2021-10-12 | The Broad Institute, Inc. | Compounds, compositions and methods for cancer treatment |
| JOP20200024A1 (ar) * | 2017-08-04 | 2020-02-02 | Bayer Ag | مركبات ثنائي هيدروكساديازينون |
-
2022
- 2022-03-02 CN CN202280018587.1A patent/CN117279644A/zh active Pending
- 2022-03-02 EP EP22710550.9A patent/EP4301371A1/en active Pending
- 2022-03-02 WO PCT/EP2022/055211 patent/WO2022184748A1/en not_active Ceased
- 2022-03-02 JP JP2023553692A patent/JP2024508171A/ja active Pending
- 2022-03-02 CA CA3212314A patent/CA3212314A1/en active Pending
- 2022-03-03 TW TW111107759A patent/TW202302113A/zh unknown
-
2023
- 2023-08-31 US US18/241,186 patent/US20230405015A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020529439A5 (enExample) | ||
| RU2455288C2 (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| HRP20171991T1 (hr) | Derivati pirolidin karbonske kiseline kao agonisti g-protein spojenog receptora (gpr43), farmaceutski pripravak i postupci za primjenu u liječenju poremećaja metabolizma | |
| JP2016528201A5 (enExample) | ||
| RU2486181C2 (ru) | Пиримидилциклопентаны как ингибиторы акт-протеинкиназ | |
| JP2019518036A5 (enExample) | ||
| JP2012517479A5 (enExample) | ||
| JP2019533694A5 (enExample) | ||
| RU2012116207A (ru) | Производные индола в качестве модуляторов crac | |
| JP2016516026A5 (enExample) | ||
| RU2011137454A (ru) | Агонисты и антагонисты s1p5-рецепторов и способы их применения | |
| RU2003112610A (ru) | Производные пиразола для лечения вирксных заболеваний | |
| RU2013103538A (ru) | 1-гидроксиимино-3-фенил-пропаны | |
| RU2014121984A (ru) | Бензолсульфонамидные соединения и их применение в качестве терапевтических средств | |
| RU2010134361A (ru) | Производные изоксазола в качестве модуляторов 11-бета-гидроксистероиддегидрогеназы 1 типа | |
| JP2020511452A5 (enExample) | ||
| RU2018104868A (ru) | 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 | |
| JP2005534672A5 (enExample) | ||
| CA2670605A1 (en) | Substituted arylpyrazoles | |
| JP2016523935A5 (enExample) | ||
| RU2021133444A (ru) | Производные бензимидазола в качестве модуляторов ror-гамма | |
| JP2013531070A5 (enExample) | ||
| JP2021098692A5 (enExample) | ||
| JP2018521119A5 (enExample) | ||
| JP2019536810A5 (enExample) |